Ovid Therapeutics's total assets for Q1 2026 were $225.63M, an increase of 49.49% from the previous quarter. OVID total liabilities were $27.36M for the fiscal quarter, a 34.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.